We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Irinotecan (CPT11) Plus High-dose 5-Fluorouracil (5-FU) and Leucovorin (LV) as Salvage Therapy for Metastatic Colorectal Cancer (MCRC) after Failed Oxaliplatin Plus 5-FU and LV: a Pilot Study in Taiwan.
- Authors
Tai, Cheng-Jeng; Liu, Jin-Hwang; Chen, Wei-Shon; Lin, Jen-Kou; Wang, Wei-Shu; Yen, Chueh-Chuan; Chiou, Tzeon-Jye; Chen, Po-Min
- Abstract
Background: Irinotecan (CPT11) has established activity against advanced colorectal cancer without cross-resistance with 5-fluorouracil + leucovorin-based therapy. We conducted this pilot study to evaluate the efficacy and tolerance of combination treatment with irinotecan and 5-fluorouracil (5-FU) for patients in whom combination treatment with oxaliplatin with 5-FU + leucovorin has failed.
- Publication
Japanese Journal of Clinical Oncology, 2003, Vol 33, Issue 3, p136
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyg023